Tech Company Financing Transactions
AdvanDx Funding Round
AdvanDx secured a $15 million Series C funding round on 9/18/2007. Backers included bioMerieux and SLS Invest AB.
Transaction Overview
Company Name
Announced On
9/18/2007
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series C
Investors
bioMerieux (Herb Steward)
SLS Invest AB (Hans Andreasson)
Proceeds Purpose
This latest financing will be used to accelerate the commercialization of AdvanDx's product pipeline through its global sales and marketing operations as well as to expand its world class research and development activities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Trade Ctr. 6990
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
Rapid diagnostics for critical infections. Improving antibiotic decisions and patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Langer
Chief Financial Officer
Tucker Kelly
VP - Bus. Development
James Coull
Browse more venture capital transactions:
Prev: 9/18/2007: BioMicro Systems venture capital transaction
Next: 9/18/2007: StreetFire venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs